drugset / Trial / NCT04598607
Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
This study will investigate the tolerability and pharmacokinetics of Hypidone Hydrochloride by multiple doses in 36 healthy male and female subjects who are of 18 to 55 years old.
Timeline
- Start
- 2020-10-30
- Primary completion
- 2021-01-11
- Completion
- 2021-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypidone Hydrochloride | Unknown | 30 mg | Oral |
| Subject | Hypidone Hydrochloride | Unknown | 40 mg | Oral |
| Subject | Hypidone Hydrochloride | Unknown | 50 mg | Oral |